Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

IFNγ-primed MSC secretomes can improve joint health by reducing inflammation and supporting tissue repair.

Early and aggressive treatment is crucial for preserving vision in infants with AEC syndrome.

Orbital decompression surgery for Graves' orbitopathy caused double vision in 19% of patients, with similar rates for two surgical methods.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

The document's conclusion cannot be provided because the document is not accessible or understandable.

The man's symptoms improved after treating his scurvy with high-dose vitamin C.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Ankylosing spondylitis does not increase the risk of hair loss.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Start with 2.5 mg/mL triamcinolone acetonide for scalp alopecia areata and increase if needed.

Congenital atrichia with papular lesions causes permanent hair loss in children.

THA is a rare condition with no significant clinical consequences if thyroid function is normal.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Mutations in certain receptors can cause diseases and offer new treatment options.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Clouston's syndrome is a rare disorder affecting nails, hair, teeth, and skin, caused by a gene mutation, and currently has no treatment, only supportive care.

Kikuchi–Fujimoto disease can cause scarring alopecia and should be considered in diagnosis.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Chlormadinone acetate is useful for birth control and treating various hormonal issues.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.